Olima Ventures

Vijay, the sole named principal, makes all investment decisions. He describes himself as an engineer, entrepreneur, and investor. No other investment professionals, partners, or investment committee members are disclosed. This single-decision-maker structure means sourcing, diligence, and portfolio support all route through one person.

Olima does not publicly describe a sourcing model, but the pattern of investments suggests network-driven origination. Vijay's early bets in Heroku, 280 North, and Octopart date to the late-2000s developer-tools era, which likely seeded relationships that later led to positions in Deel, Orkes, and Materialize. The firm does not appear to employ a dedicated sourcing team or publish sector theses that attract inbound flows.

Olima Ventures does not disclose any fund structures, limited partners, or regulatory filings that would indicate a traditional blind-pool venture fund. The website lists direct investments by stage and round without reference to fund names or vehicles. This is consistent with a permanent-capital or single-family-office model where all capital is proprietary (Altss estimate).

Olima invests predominantly at the seed stage (per firm website). Roughly 70% of disclosed rounds are tagged as Seed or Pre-seed, with the remainder split across Angel and Series A. The firm occasionally participates in Series B rounds, as with Eigen and Canary Technologies, but does not lead later-stage deals.

The portfolio concentrates in biotech (BigHat Biosciences, Venostent, Arda, Eigen, Vistapath, Condor), enterprise software and developer tools (Deel, Heroku, Materialize, Orkes, Plasmic, Kaskada), and fintech (Unit21, Lenkie, XCLAIM). Smaller allocations exist in consumer (Wish, ROOM), education (Awari, Wise), and frontier tech (SBX Robotics, Antithesis).

Olima does occasionally participate in follow-on rounds, as seen with nura (Seed and Series A), Seed & Spark (Angel and Series A), and Italic (Seed and Series A). However, follow-on behavior is not systematic, and many portfolio companies receive only a single disclosed check from the firm.

No philanthropic foundation, family-office structure, or separate investment entity is disclosed. The firm does not use family-office language on its website, though the proprietary-capital, solo-decision-maker profile is common among single-family offices operating under an asset-manager label (Altss estimate).